Orthocare Innovations

Peter Binas

Peter joined Schooner Capital in 2008 as a Managing Director after almost ten years with management consultancy McKinsey & Company. While there, Peter specialized in corporate finance and strategy, advising leading players in the consumer packaged goods and retail industries in the US, Latin America and Western Europe. Core areas of focus included mergers and acquisitions, new market entry and growth strategies, competitive strategy, post-merger integration, and operational effectiveness.

In addition to serving on the Orthocare Innovations board, Peter serves as a director on the board of RailComm. He holds a JD/MBA from Harvard Law and from Harvard Business School where he was a Baker scholar, and an AB with Honors from Harvard University where he graduated Phi Beta Kappa in Economics and Social Studies.

David Boone

Dr. Boone has spent the past twenty years as an innovator, developer, researcher and instructor in rehabilitation and bioengineering. A frequent lecturer at academic medical centers on a range of prosthetic and rehabilitation topics and a widely published author, he is credited with multiple technology patents, including a foot scanning technology that was licensed to Nike. Recently, in the field of prosthetics, he was the inventor and lead developer with the support of the National Institutes of Health of two new patent pending alignment technologies: Compas™ and RoboPAL.

Dr. Boone received his Ph.D. in Bioengineering from The Hong Kong Polytechnic University and became one of fewer than ten American Ph.D.s with formal training and clinical experience in prosthetics. He began his work in prosthetics and prosthetic research under the direction of a pioneer in the field, Dr. Ernest Burgess, and later assumed leadership of Dr. Burgess’ lab, Prosthetic Research Study (PRS) in Seattle. Dr. Boone was recently named Editor-in-Chief of the Journal of Prosthetics and Orthotics by the American Academy of Orthotists and Prosthetists.

Ted Henderson

Ted has been a Managing Director at Schooner Capital since 2004. He invests in U.S. venture and growth equity companies, as well as in alternative asset funds, with a particular focus on emerging markets. He serves as Chairman at Millstone Medical Outsourcing and Iron Rail Group. In addition to his directorship at Orthocare Innovations, Ted's current and past directorships include Best Doctors, Coastal Clubs, Seventh Generation, SRS Medical, and StyleFeeder.

Founder and CEO of several start-up enterprises in the for-profit education sector, Ted was a general manager at subsidiaries of The Washington Post Company, worked in venture capital at Fidelity Capital, and served global clients in advertising and marketing at Leo Burnett Company in Chicago.

He is a past director of The Rassias Foundation, Open Source Radio, and Grassroot Soccer. Ted received an MBA from Harvard Business School and is a cum laude graduate of Dartmouth College, with a degree in Chinese language and culture.

Doug McCormack

Mr. McCormack has spent the past eighteen years working at the intersection of politics, policy, law and business assisting organizations and corporations, including early stage companies, in the medical technology and health care industries achieve strategic growth objectives.

A recognized Washington D.C. advocate and strategist, Mr. McCormack has achieved extraordinary success on behalf of a range of interests in the O&P field, including: Amputee Coalition of America, American Academy of Orthotists & Prosthetists, Otto Bock HealthCare, Hanger Orthopedic Group and Survivor Corps (formerly Landmine Survivors Network).

Prior to co-founding Orthocare Innovations, Mr. McCormack was a partner in a national law firm practicing as a public policy and health care lawyer in the firm's Washington office. Mr. McCormack studied Political Science and Biomedical Engineering at the University of Southern California, and earned his Juris Doctorate from the American University Washington College of Law.

He serves on the boards of directors of Survivor Corps and Oklahoma Bioscience Association. He recently completed a five-year term on the Defense Health Board as an appointee of the U.S. Secretary of Defense.